T2	Exp 120 145	The double NF-kappaB site
T3	Exp 160 167	the LTR
T4	Exp 171 205	the human immunodeficiency virus-1
T5	Exp 302 304	we
T6	Exp 436 440	that
T7	Exp 313 333	the characterisation
T8	Exp 388 412	the HIV-1 NF-kappaB site
T9	Exp 290 301	this report
T10	Exp 536 547	the nucleus
T11	Exp 551 562	these cells
T12	Exp 600 602	we
T13	Exp 569 576	the use
T14	Exp 619 634	the composition
T15	Exp 638 650	each complex
T16	Exp 696 707	The results
T17	Exp 713 725	the presence
T18	Exp 768 792	the transactivating RelA
T19	Exp 830 844	The importance
T20	Exp 918 927	the level
T21	Exp 1050 1081	their syncytia-forming capacity
T22	Exp 1029 1033	that
T23	Exp 1169 1194	the actively fusing cells
T24	Exp 1196 1211	The correlation
T25	Exp 1227 1236	the level
R4	Coref Anaphora:T6 Antecedent:T26
R5	Coref Anaphora:T22 Antecedent:T27
R6	Coref Anaphora:T21 Antecedent:T27
T1	Protein 788 792	RelA
T26	Exp 416 434	human 8e51 T-cells
T27	Exp 1018 1028	8e51 cells
